BIIB : Biogen stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
| year | Average | Low | High | Change from close on 2024-10-14 |
|---|---|---|---|---|
| 2024 | $203.22 | $195.8 | $210.64 | 6.09% |
| 2025 | $693.09 | $238.03 | $1154.95 | 261.81% |
| 2026 | $1503.34 | $1235.93 | $1642.74 | 684.79% |
| 2027 | $1618.58 | $1498.45 | $1665.73 | 744.95% |
| 2028 | $1439.61 | $1384.5 | $1486.09 | 651.52% |
| 2029 | $1147.44 | $849.13 | $1408.58 | 499.0% |
| 2030 | $735.87 | $701.79 | $822.77 | 284.15% |
| 2031 | $825.82 | $721.11 | $969.35 | 331.1% |
| 2032 | $1145.18 | $1008.68 | $1211.14 | 497.82% |
| 2033 | $1219.05 | $1199.65 | $1246.62 | 536.38% |
| 2034 | $1249.77 | $1242.69 | $1258.1 | 552.42% |
The 38 Wall Street analysts offering Biogen stock forecast in the last 6 months have average price target of
$273.97 with a high forecast of $342.0 and a low forecast of $190.0.
The average Biogen stock forecast represents a 43.02%
increase from the last price of $191.559997558594.
For Biogen stock forecast for 2024, 2 predictions are offered for each month of 2024 with average Biogen stock
forecast of $203.22, a high forecast of $210.64, and a low forecast of $195.8.
The average Biogen stock forecast 2024 represents a 6.09%
increase from the last price of $191.559997558594.
For Biogen stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Biogen stock
forecast of $693.09, a high forecast of $1154.95, and a low forecast of $238.03.
The average Biogen stock forecast 2025 represents a 261.81%
increase from the last price of $191.559997558594.
For Biogen stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Biogen stock
forecast of $1618.58, a high forecast of $1665.73, and a low forecast of $1498.45.
The average Biogen stock forecast 2027 represents a 744.95%
increase from the last price of $191.559997558594.
For Biogen stock forecast for 2029 (5 year), 12 predictions are offered for each month of 2029 with average Biogen stock
forecast of $1147.44, a high forecast of $1408.58, and a low forecast of $849.13.
The average Biogen stock forecast 2029 represents a 499.0%
increase from the last price of $191.559997558594.
For Biogen stock forecast 2030, 12 predictions are offered for each month of 2030 with average Biogen stock
forecast of $735.87, a high forecast of $822.77, and a low forecast of $701.79.
The average Biogen stock forecast 2030 represents a 284.15%
increase from the last price of $191.559997558594.
For Biogen stock forecast for 2034 (10 year), 10 predictions are offered for each month of 2034 with average Biogen stock
forecast of $1249.77, a high forecast of $1258.1, and a low forecast of $1242.69.
The average Biogen stock forecast 2034 represents a 552.42%
increase from the last price of $191.559997558594.
Please, see more forecasts below.
BIIB : Biogen stock forecast by Wall Street Analysts
The average Biogen stock forecast from last 6 month is $273.97, and this show a -3.73% decrease in average from the prior price target of the each prediction. Also, this average forecast of $273.97 represents a -8.11% decrease from the past average forecast of $298.16, 6 months ago from 32 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-10-10 | Raymond James | Market Perform | ||
| 2024-10-04 | RBC Capital | $292.00 | $269.0000 | Outperform |
| 2024-10-03 | UBS | $234.0000 | $202.0000 | Neutral |
| 2024-09-24 | Needham | $285.00 | $285.00 | Buy |
| 2024-09-23 | Wedbush | $210.00 | $205.0000 | Neutral |
| 2024-09-19 | RBC Capital | $292.00 | $292.00 | Outperform |
| 2024-09-09 | Cantor Fitzgerald | $292.0000 | $292 | Overweight |
| 2024-09-04 | Needham | $285.00 | $285.00 | Buy |
| 2024-08-19 | Needham | $285.00 | $285.00 | Buy |
| 2024-08-06 | Mizuho | $277.00 | $251 | Outperform |
| 2024-08-05 | Needham | $288.00 | $285.00 | Buy |
| 2024-08-05 | Truist Securities | $340.00 | $302.0000 | Buy |
| 2024-08-02 | Wedbush | $215.00 | $210 | Neutral |
| 2024-08-02 | Barclays | $200.00 | $190.0000 | Equal-Weight |
| 2024-08-02 | Scotiabank | $275.0000 | $244.0000 | Sector Outperform |
| 2024-08-02 | Wells Fargo | $240.00 | $225.0000 | Equal-Weight |
| 2024-08-02 | RBC Capital | $282.0000 | $292 | Outperform |
| 2024-08-01 | Needham | $288.0000 | $288 | Buy |
| 2024-07-29 | Baird | $316.00 | $294 | Outperform |
| 2024-07-26 | Needham | $294.00 | $294.00 | Buy |
| 2024-07-12 | Piper Sandler | $335.0000 | $313 | Overweight |
| 2024-06-28 | Needham | $294.00 | $294.00 | Buy |
| 2024-06-27 | RBC Capital | $317.00 | $317.00 | Outperform |
| 2024-06-26 | RBC Capital | $317.00 | $317.00 | Outperform |
| 2024-06-05 | RBC Capital | $317.00 | $317.00 | Outperform |
| 2024-05-29 | RBC Capital | $317 | Outperform | |
| 2024-05-23 | HC Wainwright & Co. | $300.0000 | Buy | |
| 2024-05-22 | Needham | $294.0000 | Buy | |
| 2024-05-16 | Truist Securities | $340.00 | $340 | Buy |
| 2024-05-03 | HSBC | $339.0000 | $342.0000 | Buy |
| 2024-04-29 | Oppenheimer | $270.00 | $270 | Outperform |
| 2024-04-25 | Needham | $294.00 | Buy | |
| 2024-04-25 | HC Wainwright & Co. | $325.00 | $300.0000 | Buy |
| 2024-04-25 | Wedbush | $213.0000 | $215 | Neutral |
| 2024-04-25 | Barclays | $215.00 | $200.0000 | Equal-Weight |
| 2024-04-24 | Needham | $294.00 | Buy | |
| 2024-04-19 | Oppenheimer | $290.00 | $270 | Outperform |
| 2024-04-17 | UBS | $250.00 | $214.0000 | Neutral |
| 2024-04-17 | Wedbush | $245.0000 | $213.0000 | Neutral |
| 2024-04-12 | B of A Securities | $280.0000 | $260 | Neutral |
| 2024-04-11 | JP Morgan | $270.0000 | $240.0000 | Neutral |
| 2024-04-04 | Barclays | $230.0000 | $215.0000 | Equal-Weight |
| 2024-03-25 | Truist Securities | $340.0000 | Buy | |
| 2024-03-05 | RBC Capital | $364.0000 | Outperform | |
| 2024-02-22 | Mizuho | $355.0000 | $277 | Buy |
| 2024-02-20 | Canaccord Genuity | $310.0000 | $305.0000 | Buy |
| 2024-02-20 | Cantor Fitzgerald | $311.0000 | Overweight | |
| 2024-02-16 | UBS | $276.00 | $250 | Neutral |
| 2024-02-14 | Oppenheimer | $295.00 | $290 | Outperform |
| 2024-02-14 | Baird | $333.0000 | $316 | Outperform |
| 2024-02-14 | Piper Sandler | $350.0000 | $325 | Overweight |
| 2024-02-14 | BMO Capital | $295.0000 | $285 | Outperform |
| 2024-02-14 | RBC Capital | $379.0000 | $364 | Outperform |
| 2024-02-14 | Wells Fargo | $315 | $240.0000 | Equal-Weight |
| 2024-02-14 | HC Wainwright & Co. | $325.0000 | Buy | |
| 2024-02-14 | Needham | $305.00 | $300.0000 | Buy |
| 2024-02-13 | Needham | $305.0000 | Buy | |
| 2024-01-30 | Oppenheimer | $295.0000 | Outperform | |
| 2024-01-25 | UBS | $311.0000 | $276.0000 | Neutral |
| 2024-01-24 | UBS | $276.0000 | Neutral | |
| 2023-12-20 | Cantor Fitzgerald | $311.0000 | Overweight | |
| 2023-12-18 | Oppenheimer | $280.0000 | $295.0000 | Outperform |
| 2023-12-14 | Stifel | $315.0000 | $287 | Buy |
| 2023-12-07 | Raymond James | $283.0000 | Outperform | |
| 2023-11-10 | Morgan Stanley | $361.00 | $373 | Overweight |
| 2023-11-09 | Wells Fargo | $343.0000 | $365 | Overweight |
| 2023-11-09 | Wedbush | $266.0000 | $239.0000 | Neutral |
| 2023-11-09 | RBC Capital | $351.0000 | $363.0000 | Outperform |
| 2023-11-09 | BMO Capital | $314.0000 | $295.0000 | Outperform |
| 2023-10-26 | Needham | $305.0000 | Buy | |
| 2023-10-26 | Wedbush | $270.0000 | $266.0000 | Neutral |
Biogen stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2024-10-16 | $193.38 | 0.95% |
| 2024-10-17 | $198.02 | 2.40% |
| 2024-10-18 | $199.72 | 0.86% |
| 2024-10-21 | $200.11 | 0.19% |
| 2024-10-22 | $202.75 | 1.32% |
BIIB : Long term Biogen stock forecast for 2024 - 2025 - 2030
Forecast for 2024 Nov. is $195.80 , for 2025 Oct. is $1011.45 , for 2028 Oct. is $1412.88 , for 2029 Oct. is $914.81 , for 2033 Oct. is $1241.82 , and for 2034 Oct. is $1258.10.
BIIB : Biogen stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Nov. | $195.80 | 2.21% |
| 2024 Dec. | $210.64 | 7.58% |
BIIB : Biogen stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $238.03 | 13.01% |
| 2025 Feb. | $280.05 | 17.65% |
| 2025 Mar. | $338.79 | 20.97% |
| 2025 Apr. | $419.47 | 23.81% |
| 2025 May. | $524.16 | 24.96% |
| 2025 Jun. | $648.85 | 23.79% |
| 2025 Jul. | $775.16 | 19.47% |
| 2025 Aug. | $884.99 | 14.17% |
| 2025 Sep. | $962.54 | 8.76% |
| 2025 Oct. | $1011.45 | 5.08% |
| 2025 Nov. | $1078.62 | 6.64% |
| 2025 Dec. | $1154.95 | 7.08% |
BIIB : Biogen stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $1235.93 | 7.01% |
| 2026 Feb. | $1316.39 | 6.51% |
| 2026 Mar. | $1388.79 | 5.50% |
| 2026 Apr. | $1448.87 | 4.33% |
| 2026 May. | $1496.53 | 3.29% |
| 2026 Jun. | $1532.00 | 2.37% |
| 2026 Jul. | $1558.52 | 1.73% |
| 2026 Aug. | $1579.94 | 1.37% |
| 2026 Sep. | $1597.94 | 1.14% |
| 2026 Oct. | $1613.93 | 1.00% |
| 2026 Nov. | $1628.53 | 0.90% |
| 2026 Dec. | $1642.74 | 0.87% |
BIIB : Biogen stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $1655.99 | 0.81% |
| 2027 Feb. | $1664.86 | 0.54% |
| 2027 Mar. | $1665.73 | 0.05% |
| 2027 Apr. | $1662.08 | -0.22% |
| 2027 May. | $1655.94 | -0.37% |
| 2027 Jun. | $1649.88 | -0.37% |
| 2027 Jul. | $1641.24 | -0.52% |
| 2027 Aug. | $1631.70 | -0.58% |
| 2027 Sep. | $1617.01 | -0.90% |
| 2027 Oct. | $1560.06 | -3.52% |
| 2027 Nov. | $1520.04 | -2.57% |
| 2027 Dec. | $1498.45 | -1.42% |
BIIB : Biogen stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $1486.09 | -0.82% |
| 2028 Feb. | $1478.34 | -0.52% |
| 2028 Mar. | $1473.67 | -0.32% |
| 2028 Apr. | $1471.04 | -0.18% |
| 2028 May. | $1467.34 | -0.25% |
| 2028 Jun. | $1449.07 | -1.24% |
| 2028 Jul. | $1407.15 | -2.89% |
| 2028 Aug. | $1384.50 | -1.61% |
| 2028 Sep. | $1415.06 | 2.21% |
| 2028 Oct. | $1412.88 | -0.15% |
| 2028 Nov. | $1415.52 | 0.19% |
| 2028 Dec. | $1414.71 | -0.06% |
BIIB : Biogen stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $1408.58 | -0.43% |
| 2029 Feb. | $1399.70 | -0.63% |
| 2029 Mar. | $1384.35 | -1.10% |
| 2029 Apr. | $1330.33 | -3.90% |
| 2029 May. | $1272.63 | -4.34% |
| 2029 Jun. | $1206.44 | -5.20% |
| 2029 Jul. | $1124.80 | -6.77% |
| 2029 Aug. | $1037.92 | -7.72% |
| 2029 Sep. | $964.56 | -7.07% |
| 2029 Oct. | $914.81 | -5.16% |
| 2029 Nov. | $876.02 | -4.24% |
| 2029 Dec. | $849.13 | -3.07% |
BIIB : Biogen stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $822.77 | -3.10% |
| 2030 Feb. | $792.50 | -3.68% |
| 2030 Mar. | $766.84 | -3.24% |
| 2030 Apr. | $747.32 | -2.55% |
| 2030 May. | $734.18 | -1.76% |
| 2030 Jun. | $723.58 | -1.44% |
| 2030 Jul. | $713.93 | -1.33% |
| 2030 Aug. | $706.22 | -1.08% |
| 2030 Sep. | $701.79 | -0.63% |
| 2030 Oct. | $702.19 | 0.06% |
| 2030 Nov. | $706.37 | 0.59% |
| 2030 Dec. | $712.79 | 0.91% |
BIIB : Biogen stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $721.11 | 1.17% |
| 2031 Feb. | $731.75 | 1.48% |
| 2031 Mar. | $745.53 | 1.88% |
| 2031 Apr. | $763.05 | 2.35% |
| 2031 May. | $783.65 | 2.70% |
| 2031 Jun. | $806.39 | 2.90% |
| 2031 Jul. | $827.39 | 2.61% |
| 2031 Aug. | $849.88 | 2.72% |
| 2031 Sep. | $875.14 | 2.97% |
| 2031 Oct. | $902.82 | 3.16% |
| 2031 Nov. | $933.81 | 3.43% |
| 2031 Dec. | $969.35 | 3.81% |
BIIB : Biogen stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $1008.68 | 4.06% |
| 2032 Feb. | $1047.89 | 3.89% |
| 2032 Mar. | $1083.74 | 3.42% |
| 2032 Apr. | $1114.69 | 2.86% |
| 2032 May. | $1139.33 | 2.21% |
| 2032 Jun. | $1158.14 | 1.65% |
| 2032 Jul. | $1173.30 | 1.31% |
| 2032 Aug. | $1187.48 | 1.21% |
| 2032 Sep. | $1199.46 | 1.01% |
| 2032 Oct. | $1207.28 | 0.65% |
| 2032 Nov. | $1211.01 | 0.31% |
| 2032 Dec. | $1211.14 | 0.01% |
BIIB : Biogen stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $1208.71 | -0.20% |
| 2033 Feb. | $1205.28 | -0.28% |
| 2033 Mar. | $1201.87 | -0.28% |
| 2033 Apr. | $1199.65 | -0.18% |
| 2033 May. | $1200.19 | 0.04% |
| 2033 Jun. | $1204.99 | 0.40% |
| 2033 Jul. | $1214.06 | 0.75% |
| 2033 Aug. | $1224.85 | 0.89% |
| 2033 Sep. | $1234.45 | 0.78% |
| 2033 Oct. | $1241.82 | 0.60% |
| 2033 Nov. | $1246.16 | 0.35% |
| 2033 Dec. | $1246.62 | 0.04% |
BIIB : Biogen stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $1244.50 | -0.17% |
| 2034 Feb. | $1242.69 | -0.15% |
| 2034 Mar. | $1243.84 | 0.09% |
| 2034 Apr. | $1247.94 | 0.33% |
| 2034 May. | $1251.78 | 0.31% |
| 2034 Jun. | $1253.19 | 0.11% |
| 2034 Jul. | $1251.54 | -0.13% |
| 2034 Aug. | $1248.82 | -0.22% |
| 2034 Sep. | $1255.28 | 0.52% |
| 2034 Oct. | $1258.10 | 0.22% |
Frequently Asked Questions about Biogen stock forecast
Is Biogen a good long term stock?
From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2024 Nov. is $195.800893513735 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2025 Oct. is $1011.44820976302 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2028 Oct. is $1412.88343445066 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2029 Oct. is $914.805119465963 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2033 Oct. is $1241.81735425444 From Biogen stock forecast , Biogen (BIIB) stock can be a good investment choice. According to AIPickup, the Biogen stock price forecast for 2034 Oct. is $1258.09966586071
Is Biogen stock overvalued?
Biogen (BIIB) stock is expected to go UP . Therefore, AIPickup would say that Biogen (BIIB) stock is NOT overvalued.
Will Biogen stock price go up?
Yes. The Biogen stock price forecast for 2025 Oct. is $1011.44820976302
Is Biogen stock a good buy now?
Since closing price on 2024-10-14 is $191.559997558594 and forecast for 2025 Oct. is $1011.45, Biogen stock is a good 1 year investment.
14 Days Historical Data for Biogen stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| BIIB stock price for 2024-09-25 | $189.07 | $193.84 | $188.78 | $194.56 |
| BIIB stock price for 2024-09-26 | $193.60 | $191.17 | $190.50 | $193.73 |
| BIIB stock price for 2024-09-27 | $194.67 | $194.49 | $193.98 | $197.70 |
| BIIB stock price for 2024-09-30 | $193.84 | $193.36 | $192.28 | $194.48 |
| BIIB stock price for 2024-10-01 | $190.80 | $194.61 | $190.27 | $195.00 |
| BIIB stock price for 2024-10-02 | $188.74 | $190.08 | $188.05 | $191.86 |
| BIIB stock price for 2024-10-03 | $184.78 | $187.21 | $183.56 | $188.14 |
| BIIB stock price for 2024-10-04 | $185.68 | $186.68 | $183.82 | $186.80 |
| BIIB stock price for 2024-10-07 | $183.34 | $184.76 | $182.48 | $185.93 |
| BIIB stock price for 2024-10-08 | $182.30 | $182.73 | $181.31 | $183.55 |
| BIIB stock price for 2024-10-09 | $185.76 | $182.46 | $181.31 | $185.80 |
| BIIB stock price for 2024-10-10 | $188.59 | $184.56 | $184.30 | $188.88 |
| BIIB stock price for 2024-10-11 | $188.38 | $189.00 | $186.91 | $189.43 |
| BIIB stock price for 2024-10-14 | $191.56 | $188.50 | $186.61 | $191.96 |